Science Explorer Back to mapMap
Discussion
Institution · Breast Cancer Network Australia

Most cited papers from Breast Cancer Network Australia

Breast Cancer Network Australia

What are the most cited papers from Breast Cancer Network Australia?

The most cited paper from Breast Cancer Network Australia is "4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)" (Fátima Cardoso et al., 2018), with 1,202 citations. Next come "Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015)" (339) and "A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer" (249).

Showing 50 of 60 papers. Every paper with more than 15 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) Fátima Cardoso et al. · Annals of Oncology Open access 23 May 2018 1,202
2 Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015) Fátima Cardoso, Danielle Spence, Shirley A. Mertz et al. · The Breast 18 Apr 2018 339
3 A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer Wee Loon Ong et al. · JAMA Oncology 29 Dec 2016 249
4 Survey of healthcare experiences of Australian adults living with rare diseases Caron M. Molster, Debra Urwin, Louisa Di Pietro et al. · Orphanet Journal of Rare Diseases Open access 24 Mar 2016 239
5 Analysis of cancer risk and BRCA1 and BRCA2mutation prevalence in the kConFab familial breast cancer resource Graham J. Mann et al. · Breast Cancer Research Open access 13 Feb 2006 155
6 Use of complementary therapies by Australian women with breast cancer T. Kremser, Alison Evans, Amber B. Moore et al. · The Breast Open access 6 Jun 2008 99
7 Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Deborah Watkins Bruner, Laura J. Hanisch, Bryce B. Reeve et al. · Translational Behavioral Medicine Open access 18 Feb 2011 92
8 The Women’s wellness after cancer program: a multisite, single-blinded, randomised controlled trial protocol Debra Jane Anderson, Charrlotte A. Seib, Dian Tjondronegoro et al. · BMC Cancer Open access 3 Feb 2017 85
9 Survivorship care after breast cancer treatment – Experiences and preferences of Australian women Meagan Elizabeth Brennan, Phyllis Noemi Butow, Michelle Marven et al. · The Breast Open access 15 Jan 2011 85
10 Telehealth in cancer care: during and beyond the COVID ‐19 pandemic Kate Burbury, Zee‐Wan Wong, Desmond Yip et al. · Internal Medicine Journal Open access 2021 83
11 Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare Zornitza Stark et al. · The American Journal of Human Genetics Open access Mar 2023 77
12 First-in-Humans Evaluation of 18 F-SMBT-1, a Novel 18 F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis Victor L. Villemagne, Ryuichi Harada, Vincent Doré et al. · Journal of Nuclear Medicine Open access 27 Jan 2022 77
13 What should doctors know about cancer? Undergraduate medical education from a societal perspective Michael Bernard Barton, Pamela Bell, Sabe S. Sabesan et al. · The Lancet Oncology Jul 2006 74
14 CenTauR: Toward a universal scale and masks for standardizing tau imaging studies Victor L. Villemagne, Antoine Leuzy, Sandra Sanabria Bohórquez et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access Jul 2023 73
15 Assessing Reactive Astrogliosis with 18 F-SMBT-1 Across the Alzheimer Disease Spectrum Victor L. Villemagne, Ryuichi Harada, Vincent Doré et al. · Journal of Nuclear Medicine Open access 27 Jan 2022 68
16 First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Antitumor Activity Hui Kong Gan, Michael Millward, Hua Ye et al. · Clinical Cancer Research 5 Apr 2019 66
17 The Australian Reproductive Genetic Carrier Screening Project (Mackenzie’s Mission): Design and Implementation Alison Dalton Archibald et al. · Journal of Personalized Medicine Open access 28 Oct 2022 64
18 Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects Kévin Martin, Gregory M. Bell, Karen Pickthorn et al. · Nephrology Dialysis Transplantation Open access 13 Nov 2013 59
19 Evidence‐based guideline for the written radiology report: Methods, recommendations and implementation challenges Stacy Goergen, Felicity Jane Pool, Tari Turner et al. · Journal of Medical Imaging and Radiation Oncology 28 Dec 2012 58
20 Religious Conversion Practices and LGBTQA + Youth Tiffany Mary Jones, Tiffany Mary Jones, Jennifer Power et al. · Sexuality Research and Social Policy Open access 6 Jul 2021 51
21 Online information and support needs of women with advanced breast cancer: a qualitative analysis Emma Kemp, Bogda Koczwara, Phyllis Noemi Butow et al. · Supportive Care in Cancer Open access 24 Apr 2018 51
22 Two-Year Results of a Randomized Placebo-Controlled Trial of Vertebroplasty for Acute Osteoporotic Vertebral Fractures Féline P B Kroon, Margaret Staples, Peter Robert Ebeling et al. · Journal of Bone and Mineral Research Open access 11 Dec 2013 51
23 Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model Antoine Leuzy et al. · Alzheimer s & Dementia Open access 23 Jul 2024 50
24 Full transmitter waveform transient electromagnetic modeling and inversion for soundings over coal measures Michael Asten · Geophysics Mar 1987 49
25 A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults James Baber, Mark Arya, Yuben P. Moodley et al. · The Journal of Infectious Diseases Open access 10 May 2022 47
26 Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options Janine Margaret Lombard, Nicholas Zdenkowski, Kathy Wells et al. · Supportive Care in Cancer 9 Nov 2015 47
27 A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers Juliette Coignard et al. · Nature Communications Open access393 authors 17 Feb 2021 40
28 Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data Marina T. van Leeuwen, Michael O. Falster, Claire Melissa Vajdic et al. · BMJ Open Open access Apr 2018 40
29 Invasive pneumococcal disease in Australia, 2004 PAUL W. ROCHE, Vicki Krause, Mark J. Bartlett et al. · Communicable Diseases Intelligence Open access Mar 2006 38
30 The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study Maria E Arriaga, Claire Melissa Vajdic, Karen Canfell et al. · International Journal of Cancer Open access 26 Feb 2019 37
31 Assessment and management of bone health in women with oestrogen receptor‐positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia Mathis Grossmann, Sabashini K. Ramchand, Frances Milat et al. · Clinical Endocrinology 9 May 2018 35
32 “I'm Healthy, It's Not Going To Be Me”: Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia Catherine Beard, David J. Amor, Louisa Di Pietro et al. · American Journal of Medical Genetics Part A 6 May 2016 35
33 Common variants in breast cancer risk loci predispose to distinct tumor subtypes Thomas U. Ahearn et al. · Breast Cancer Research Open access208 authors 4 Jan 2022 33
34 Communication about high-cost drugs in oncology—the patient view E. Kaser, Joanne Margaret Shaw, Michelle Marven et al. · Annals of Oncology Open access 25 Mar 2010 32
35 Understanding genomic health information: how to meet the needs of the culturally and linguistically diverse community—a mixed methods study Eloise Uebergang, Stephanie Best, M. De Silva et al. · Journal of Community Genetics Open access 29 Jun 2021 31
36 Women’s preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory Stephanie Tesson, Imogen Richards, David J.T. Porter et al. · Patient Education and Counseling 30 Nov 2015 25
37 Pharmacokinetics and Pharmacodynamics of the BACE 1 Inhibitor Verubecestat ( MK ‐8931) in Healthy Japanese Adults: A Randomized, Placebo‐Controlled Study K. Chris Min, Marissa Fallon Dockendorf, John S. Palcza et al. · Clinical Pharmacology & Therapeutics 22 Oct 2018 24
38 Professionally led support groups for people living with advanced or metastatic cancer: a systematic scoping review of effectiveness and factors critical to implementation success within real-world healthcare and community settings Zhicheng Li, Kitty-Jean Laginha, Frances M. Boyle et al. · Journal of Cancer Survivorship Open access 8 Jan 2024 23
39 A phase I randomized, double‐blinded , placebo‐controlled study assessing the safety and pharmacokinetics of RIPK1 inhibitor GFH312 in healthy subjects Jason D. Lickliter, Shuang Wang, Wenxin Zhang et al. · Clinical and Translational Science Open access 24 Jun 2023 23
40 Why did we fail? Challenges recruiting parents with cancer into a psycho‐educational support program Lesley Stafford, Michelle Sinclair, Louise Kathryn Newman et al. · Psycho-Oncology Open access 13 Sep 2019 23
41 Women's experiences of dating after breast cancer Laura-Kate E. Shaw, Kerry Anne Sherman, Julie Fitness et al. · Journal of Psychosocial Oncology 3 Jul 2016 23
42 What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions? Rebecca Mercieca‐Bebber, Madeleine Trudy King, Miriam M. Boxer et al. · Breast Cancer 28 Feb 2017 22
43 “SLANG”—Sensitive Language and the New Genetics—an Exploratory Study Jan M. Hodgson, Ed Hughes, Clinton E. Lambert · Journal of Genetic Counseling Open access Dec 2005 22
44 Feasibility and preliminary efficacy of iConquerFear: a self-guided digital intervention for fear of cancer recurrence Allan Ben Smith et al. · Journal of Cancer Survivorship Open access 25 Jul 2022 21
45 Assessment and management of bone health in women with oestrogen receptor‐positive breast cancer receiving endocrine therapy: position statement summary Mathis Grossmann, Sabashini K. Ramchand, Frances Milat et al. · The Medical Journal of Australia Open access 18 Jul 2019 21
46 Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial Joseph Proietto, Jaret L. Malloy, Dongliang Zhuang et al. · Diabetologia Open access 11 Jul 2018 20
47 A conceptual model of how people adopt recreation activities John E. Brandenburg, Wendy Greiner, Elery Hamilton‐Smith et al. · Leisure Studies 1982 20
48 Immunogenicity and safety of a bivalent (omicron BA.5 plus ancestral) SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose: interim analysis of a phase 3, non-inferiority, randomised, clinical trial Chijioke Bennett et al. · The Lancet Infectious Diseases Open access 6 Mar 2024 19
49 The cancer nursing workforce in Australia: a national survey exploring determinants of job satisfaction Natalie Bradford et al. · BMC Nursing Open access 6 Dec 2023 19
50 Childhood rare diseases and the UN convention on the rights of the child Lisa Matthews, Vaughan Chin, Marisa Taliangis et al. · Orphanet Journal of Rare Diseases Open access Dec 2021 19

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.